What is the normal reference range for free testosterone in a healthy premenopausal woman (regular menstrual cycles, age 18‑49 years) in pg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Free Testosterone Range in Premenopausal Women

For a healthy premenopausal woman (age 18–49 years with regular menstrual cycles), free testosterone measured by equilibrium dialysis typically ranges from approximately 1.2 to 6.4 pg/mL (4.16 to 22.2 pmol/L), with values peaking at mid-cycle around 15.6 pg/mL. 1, 2

Reference Ranges by Measurement Method

Equilibrium Dialysis (Gold Standard)

  • Free testosterone: 1.2–6.4 pg/mL (4.16–22.2 pmol/L) for a typical 30-year-old woman 1
  • Mid-cycle peak values can reach approximately 15.6 ± 11.9 pg/mL, which is higher than previously reported in older literature 2
  • The 5th to 95th percentile range was established in 161 healthy women aged 18–49 years with normal menstrual cycles 1

Calculated Free Testosterone

  • Calculated free testosterone: 1.3–5.6 pg/mL (4.5–19.4 pmol/L) for a 30-year-old woman 1
  • This method uses total testosterone and SHBG measurements to estimate free testosterone 1

Age-Specific Considerations

  • Free testosterone declines with age across the premenopausal years, even in women with regular cycles 1, 3
  • For women aged 20–80 years measured by mass spectrometry, the reference range for free testosterone is 0.0025–0.0253 nmol/L (approximately 0.72–7.3 pg/mL when converted) 3

Menstrual Cycle Variation

Follicular to Mid-Cycle Changes

  • Free testosterone increases progressively across the follicular phase and peaks at mid-cycle, coinciding with ovulation 2
  • The mid-cycle peak (approximately 15.6 pg/mL) is substantially higher than early follicular phase values 2

Luteal Phase

  • Free testosterone gradually declines during the luteal phase after the mid-cycle peak 2
  • Despite this variation, the overall reference ranges can be applied irrespective of menstrual cycle day because the mid-cycle increase is relatively small compared to overall inter-individual variability 1

Supporting Total Testosterone Values

For context, the corresponding total testosterone ranges in premenopausal women are:

  • 15–46 ng/dL (520–1595 pmol/L) for a 30-year-old woman 1
  • Mid-cycle peak: approximately 43.6 ± 16.2 ng/dL 2
  • Age 20–80 years: 0.35–1.97 nmol/L (approximately 10–57 ng/dL) 3

Critical Measurement Considerations

Importance of Accurate Methodology

  • Equilibrium dialysis coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for measuring free testosterone in women 2
  • Traditional immunoassays offer limited precision and specificity in the low concentration range typical of women and should be avoided 3

Bioavailable Testosterone

  • Bioavailable testosterone: 1.12–7.62 ng/dL (38.8–264.21 pmol/L) represents testosterone not bound to SHBG and is another measure of biologically active androgen 1

SHBG Reference Range

  • SHBG: 18–86 nmol/L in premenopausal women, which remains relatively stable across age ranges 1

Clinical Pitfalls to Avoid

  • Do not use direct immunoassay methods for free testosterone measurement in women, as they lack accuracy in the low concentration range 3
  • Do not assume a single reference range applies to all ages—free testosterone declines significantly with age even in healthy premenopausal women 1, 3
  • Be aware that mid-cycle values can be substantially higher (up to 15.6 pg/mL) than previously reported ranges, which may lead to misdiagnosis of hyperandrogenism if menstrual phase is not considered 2
  • Recognize that women have a DHT-to-testosterone ratio of approximately 1:4, which is significantly higher than the 1:13 ratio in men, though the clinical significance of this difference requires further investigation 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.